2006
DOI: 10.1507/endocrj.53.225
|View full text |Cite
|
Sign up to set email alerts
|

Activation of Follistatin Promoter by GnRH in LβT2 Gonadotroph Cells

Abstract: Abstract. Follistatin (FS) is produced and secreted from gonadotroph cells in pituitary gland as well as granulosa cells in the ovary. In the present study, we found that the FS promoter is activated by GnRH in the gonadotroph cell line, LbT2. Therefore, we examined the signal transduction pathways involved in the mechanism. The activation of the FS promoter by GnRH was inhibited by calphostin C, a protein kinase C inhibitor, and U0126, a MAP kinase kinase (MEK) inhibitor. Phosphorylation by protein kinase C o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2009
2009
2018
2018

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 41 publications
(32 reference statements)
0
2
0
Order By: Relevance
“…Inhibins act to reduce FSH secretion; activins stimulate FSH production by gonadotropic cells, while follistatins suppress FSH via binding to and inactivation of activins (Winters and Moore, ). By inhibiting tyrosine‐kinase, genistein might have interrupted the pathway of follistatin promoter activation (Kihara et al, ), allowing stimulation of FSH production by activin.…”
Section: Discussionmentioning
confidence: 99%
“…Inhibins act to reduce FSH secretion; activins stimulate FSH production by gonadotropic cells, while follistatins suppress FSH via binding to and inactivation of activins (Winters and Moore, ). By inhibiting tyrosine‐kinase, genistein might have interrupted the pathway of follistatin promoter activation (Kihara et al, ), allowing stimulation of FSH production by activin.…”
Section: Discussionmentioning
confidence: 99%
“…The promoters of the rat or human FST genes have been evaluated in a variety of cell lines and shown to be targets of inputs such as the cAMP/TPA pathway in P19 and F9 embryonic carcinoma cells [184, 185], the Wnt/β-catenin pathway in NCCIT human embryonic carcinoma and F9 teratocarcinoma cells [186, 187] and by PPARα and PPARγ nuclear receptors in LβT2 cells [188]. GnRH activates the Fst promoter in LβT2 cells [189191]. In non-pituitary cells such as HepG2 or HEK293T cells, the Fst promoter is induced by activin or TGF-β via Smad2/3 [192, 193].…”
Section: Gonadotrope-specific Activation Of Follistatin By Activinmentioning
confidence: 99%